inrebic

Frequently asked questions

What does Inrebic treat?

Inrebic (Fedratinib Hydrochloride) may be used to treat primary myelofibrosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Inrebic?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Inrebic. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Inrebic?

Inrebic is marketed by Bristol-Myers. You can see Bristol-Myers's full profile, rating, and other products on pharmaranks.

Is Inrebic a brand-name or generic drug?

Inrebic is a brand-name product with the active ingredient Fedratinib Hydrochloride.

Is Inrebic available over the counter?

No. Inrebic is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Inrebic come in?

Inrebic is currently marketed as capsule, per the FDA's National Drug Code Directory.

Is Inrebic FDA-registered?

Inrebic is on record with the U.S. FDA under application number NDA212327. You can verify this on its official FDA label.